Clean cannabis oil and asthma help? In some cases I have even seen patients who had no fear of this medication, ingest the full 60-gram treatment in one month and after doing so, many of them were declared to be cancer-free. By using the method which I am describing, it allows your body time to build up a tolerance for this medication slowly and once the patient becomes accustomed to the effects of the oil, most patients actually report that they enjoy taking it. We all have different tolerances for any medication and your size or body weight has little to do with your tolerance for hemp oil and even children can take the same dosage as adults, with no detrimental effects. Find more info at Rick Simpson oil.
The best light intensity for plant growth during flowering: Plant growth rate increases up to PAR (PPFD) levels of 1,500 µmols/m2/sec at optimum temperature and atmospheric levels of CO2. We recommend a PAR level of 750 µmols/m2/sec for your grow room. Increasing PAR above this level does not increase the growth rate enough to justify the additional energy consumed. The PAR levels (PPFD) vs Photosynthesis (Growth Rate) for Cannabis Sativa at 30 Degrees Celcius and normal atmospheric CO2 levels.
How to make Rick Simpson Oil? Rick Simpson Oil (RSO) is a high potency cannabis extract with high levels of THC, along with other cannabinoids. Many researches have demonstrated its health benefits as a substitute or an assist for prescription drugs. It is widely used for the treatment of cancers. RSO is a special oil extracted from the flowers and upper leaves of cannabis plants. With the use of RSO for centuries as a special natural herb, oil from cannabis is continually gaining a reputation in different parts of the world. RSO is highly beneficial and widely considered by many to be one of the most effective oils for the alleviation of certain illnesses and conditions. See more information at rsocancerfree.com.
Tommy Chong on battling rectal cancer by using cannabis oil. Currently, 18 states have legalized the recreational use of marijuana and 36 states have legalized the medicinal use of cannabis. Many cancer patients (16-24%) use cannabis oil to curtail symptoms related to cancer or cancer treatment. Dr. Newcomb, the first author of the publication, stated that “cannabis has some important properties that motivate cancer patients to use it for nausea and vomiting, appetite, pain, fatigue.” Previous studies indicate that cannabis is widely used among cancer patients with late-stage disease or with other poor mental or physical health states. Due to improvements in early detection and cancer treatments, the number of cancer survivors will expand by one million per year, which includes at least 150,000 colorectal cancer (CRC) patients. Therefore, about 2.7 to 4 million survivors may intentionally use cannabis for symptom management or other reasons. Presently, cannabis use and its side effects are not monitored among cancer patients and survivors. The Newcomb Group, from the Division of Public Health Sciences, evaluated the demographic, behavioral, and clinical characteristics of cannabis use among colorectal cancer patients from Washington State. CRC has a high prevalence and several treatments with side effects thus, CRC provides a good model for understanding cannabis use among men and women with cancer. This study is published in Cancer Causes & Control.
CBD was approved by FDA in 2018 to treat children’s epilepsy, which is the maximum recognition of its safety. Our results suggest that CBD indications may expand to glioma, especially the clinical first-line chemotherapy drug timomamide The combination may have a better effect. We are actively promoting the clinical experiments initiated by researchers; but according to existing regulations, it is possible to choose the drug-label use .The Patient Cannot Wait ! “Talking about the future application prospects, Yan Chao is full of expectations. Professor Yan Chao, Nanjing University, Associate Professor Liu Xiangyu, a Gulou Hospital, and Professor Hang Chunhua as the commonal information of the paper, and Nanjing college student’s Ph.D. Huang Tunfei’s first author of the paper.